Second-line treatment options in advanced non-small cell lung cancer

被引：5
|
作者：
de Marinis, Filippo [1 ]
Ricciardi, Serena [1 ]
机构：
[1] San Camillo Forlanini High Specializat Hosp, Lung Dis Dept, Pulm Oncol Unit 1, Rome, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
RANDOMIZED PHASE-III; PREVIOUSLY TREATED PATIENTS; GROWTH-FACTOR RECEPTOR; QUALITY-OF-LIFE; EVERY; WEEKS; SINGLE-AGENT; MOLECULAR PREDICTORS; PLUS GEMCITABINE; WEEKLY DOCETAXEL; SUPPORTIVE CARE;
D O I：
10.1016/S0959-8049(11)70172-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：S258 / S271
页数：14
相关论文
共 50 条
  • [31] Prognostic Significance of HALP Score in Second-Line Nivolumab Treatment of Advanced Non-Small Cell Lung Cancer
    Akgul, Fahri
    Gokmen, Ivo
    Gulbagci, Burcu
    Bayrakci, Ismail
    Divriklioglu, Didem
    Bakir Kahveci, Gizem
    Akkus, Aysun Fatma
    Aydin, Tayyip Ilker
    Hacioglu, Bekir
    Erdogan, Bulent
    Topaloglu, Sernaz
    NAMIK KEMAL MEDICAL JOURNAL, 2025, 13 (01): : 6 - 12
  • [32] Phase II trial of temozolomide and irinotecan as second-line treatment for advanced non-small cell lung cancer
    Choong, Nicholas W.
    Mazcer, Ann M.
    Hoffman, Philip C.
    Rudin, Charles M.
    Winegarden, Jerome D., III
    Villano, J. Lee
    Kozloff, Mark
    Wade, James L., III
    Sciortino, David F.
    Szeto, Livia
    Vokes, Everett E.
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (03) : 245 - 251
  • [33] Second-line therapeutic options in non-small-cell lung cancer
    Vansteenkiste, Johan
    LUNG CANCER, 2006, 54 : S15 - S18
  • [34] Second-Line Chemotherapy and Beyond for Non-Small Cell Lung Cancer
    Durm, Greg
    Hanna, Nasser
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2017, 31 (01) : 71 - +
  • [35] Considerations for second-line therapy of non-small cell lung cancer
    Stinchcombe, Thomas E.
    Socinski, Mark A.
    ONCOLOGIST, 2008, 13 : 28 - 36
  • [36] Second-line therapy and advanced non-small cell lung cancer: What about smoking?
    Braillon, Alain
    LUNG CANCER, 2018, 122 : 257 - 257
  • [37] Efficacy of second-line chemotherapy after immunotherapy in advanced non-small cell lung cancer
    Hirata, Tsuyoshi
    Hakozaki, Taiki
    JOURNAL OF THORACIC DISEASE, 2023, 15 (07) : 3554 - 3556
  • [38] Second-line envafolimab and beyond in locally advanced or metastatic non-small cell lung cancer
    Guan, M.
    Shi, Q.
    ANNALS OF ONCOLOGY, 2024, 35
  • [39] Outcomes of Second-Line Chemotherapy for Advanced Non-Small Cell Lung Cancer in One Institution
    Lee, Seok Jeong
    Kang, Hyun Ju
    Kim, Seo Woo
    Ryu, Yon Ju
    Lee, Jin Hwa
    Kim, Yookyung
    Chang, Jung Hyun
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2014, 77 (01) : 13 - 17
  • [40] Weekly docetaxel and vinorelbine as second-line therapy in advanced non-small cell lung cancer
    Huber, R
    Schmidt, M
    Borgmeier, A
    LUNG CANCER, 2005, 49 : S248 - S248
12345